Article info

Download PDFPDF

Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context

Authors

  1. Correspondence to Dr Diana V Do; dianado{at}stanford.edu
View Full Text

Citation

Do DV, Moini H, Wykoff CC
Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context

Publication history

  • First published August 1, 2022.
Online issue publication 
August 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.